Login
$BLNC
$1.55 -$0.02 (1.27%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
ASSETS
Current Assets
Cash and cash equivalents
Accounts receivable, net of allowance of $0 and $0 as of December 31, 2023 and 2022.
Investment at fair value - related party
Related Party
Nonrelated Party
Total investment at fair value - related party
Marketable securities — related party
Unbilled receivable
Total Current Assets
Investment at fair value - related party
Total Assets
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities
Accounts payable and accrued expenses
Accounts expenses – related party
Related Party
Total accounts expenses – related party
Accounts payable — related party
Short-term advances — related party
Convertible note payable
Convertible note payable — in default
Related Party
Notes Payable One
Notes Payable Two
Nonrelated Party
Total convertible note payable — in default
Convertible notes payable - related party, net of debt discount of $0 and $0, as of June 30, 2023 and December 31, 2022
Convertible note payable, net of debt discount
Convertible note payable, net of debt discount of $0 and $0, as of March 31, 2025 and December 31, 2024
Notes payable — related party, in default
Related Party
Total notes payable — related party, in default
Derivative liability
Total Current Liabilities
Convertible note payable, net of debt discount of $ 19,845 as of December 31, 2022
Total Liabilities
Stockholders’ Deficit
Common stock, $0.0001 par value: 500,000,000 shares authorized; 46,852,319 and 46,852,319 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Total Stockholders’ Deficit
Total Stockholders’ Deficit
Total Liabilities and Stockholders’ Deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support